Catatonic schizophrenia is a type of psychotic disorder marked by severe disruptions in movement and behavior. People with this condition may become completely unresponsive, unable to move, speak, or follow instructions. This is known as catatonic stupor. ¹

But not everyone experiences it the same way. Some people swing to the opposite extreme, entering a state called catatonic excitement, a period of excessive, agitated motor activity that can appear sudden and unpredictable.

Both states may include secondary symptoms like echolalia (repeating or mimicking sounds) and echopraxia (involuntarily copying another person’s movements). These symptoms can be disorienting for the person experiencing them and for those around them.

---

Key Highlights

• Symptoms and diagnosis – Catatonic schizophrenia is marked by severe disruptions in movement and behavior (ranging from complete unresponsiveness to episodes of excessive agitation) and requires at least three recognized symptoms to be clinically diagnosed.

• Causes and risk factors – No single cause has been identified, but a combination of genetic, environmental, and psychological factors (including family history, childhood trauma, and chronic stress) can increase a person’s risk of developing the condition.

• Treatment and recovery – Catatonic schizophrenia is a lifelong condition, but it’s manageable. A combination of medication, therapy, and consistent care gives most people the ability to reduce episodes and live a full, meaningful life.

---

Table of Contents

---

What are Catatonic Schizophrenia Symptoms?

Catatonic schizophrenia symptoms fall into two broad categories: decreased motor activity and increased motor activity. A clinical diagnosis of catatonia requires at least three of the following symptoms to be present: ²

• Agitation – heightened restlessness or emotional distress
• Catalepsy – holding unusual, rigid body postures
• Echolalia – repeating or mimicking another person’s speech
• Echopraxia – copying another person’s movements
• Grimacing – making involuntary or distorted facial expressions
• Mannerism – exaggerated or peculiar gestures and actions
• Mutism – little to no verbal communication
• Negativism – resistance or no response to instructions
• Posturing – maintaining a position that works against gravity
• Stereotypy – repeating a movement without any clear purpose
• Stupor – inability to move or interact with the surrounding environment
• Waxy flexibility – allowing a limb to remain in whatever position it’s placed

The duration of catatonic episodes varies widely. Some people experience a single episode lasting a few days; others remain in one for several weeks.

It’s also worth noting that catatonia isn’t exclusive to schizophrenia. Thanks to improved treatments, it’s become less common in schizophrenic patients overall. And it actually appears more frequently in people with other conditions, such as:

• Depressive disorders
• Neurodevelopmental (which primarily affects the developing nervous system in children)
• Psychotic bipolar disorder

What are Schizophrenia Symptoms?

Beyond catatonic symptoms, a person with catatonic schizophrenia may also experience the broader symptoms of schizophrenia, including: ³

• Auditory or visual hallucinations
• Delusional thoughts (believing something is real when it isn’t)
• Difficulty concentrating and retaining information (learning problems)
• Disorganized speech
• Easily distracted
• Lack of overall joy and happiness
• Loss of interest in activities you once enjoyed
• Reduction in speaking and conversing with others
• Unable to show emotions (some psychiatrists refer to this as “flat expression”)

Because catatonic and schizophrenia symptoms can overlap and intensify one another, many people are unable to seek help independently. This is where family members and close friends play a critical role, helping guide loved ones toward evaluation and care.

Causes and Risk Factors

Researchers haven’t pinpointed a single cause of catatonic schizophrenia. What we do know is that several biological, environmental, and psychological factors can increase a person’s risk of developing the condition:

• Childhood Abuse and Trauma – Experiencing physical, emotional, or sexual trauma in childhood raises the likelihood of developing schizophrenia and other mental health conditions. ⁴

• Fetal Malnutrition – When a fetus doesn’t receive adequate nutrition during pregnancy, the risk of developing schizophrenia later in life increases. ⁵

• Genetics – A family history of schizophrenia is one of the strongest known risk factors. If a close relative has been diagnosed, your risk is statistically higher. ⁶

• Parents Age at Birth – Research suggests that children born to older parents face a greater risk of developing schizophrenia, though the exact reason isn’t fully understood. ⁷

• Stress – Prolonged or early-life stress can elevate the risk of many mental health conditions, including schizophrenia, particularly in people who already have a biological vulnerability to it. ⁹

• Viral Infection – Some studies indicate that childhood exposure to certain viral infections may contribute to a higher risk of schizophrenia. ¹⁰

It’s also worth noting that substance abuse has been linked to schizophrenia, but with an important distinction. Drugs or alcohol appear to trigger the condition only in people who are already predisposed to it, rather than causing it independently.

Catatonic Schizophrenia Diagnosis

Diagnosing catatonic schizophrenia isn’t a single-step process. Because many of its symptoms overlap with other medical and psychiatric conditions, doctors work through a series of tests to rule out other causes before reaching a confirmed diagnosis. These typically include: ¹²

• Complete Blood Count (CBC) – Screens for alcohol or drug use and helps identify any underlying physical conditions that could be producing psychiatric symptoms.

• Electroencephalogram (EEG) – Measures electrical activity in the brain, giving doctors a clearer picture of how the brain is functioning.

• MRI and/or CT Scan – Checks for structural abnormalities in the brain that may point toward schizophrenia or another neurological condition.

• Psychological Evaluation – A psychiatrist conducts an in-depth interview covering your thoughts, feelings, behaviors, symptom history, and severity. Family history is also explored during this stage.

• Physical Exam – Assesses your overall physical health and helps determine whether another condition might be contributing to your symptoms.

Because the diagnostic process is designed to eliminate other possibilities first, it can take time before your doctor arrives at a definitive diagnosis. This can be frustrating, but it’s an important step toward getting the right treatment.

How to Treat Catatonic Schizophrenia

Treatment for catatonic schizophrenia depends on your age, overall health, and the severity of your symptoms. That said, it generally follows the same approach used for schizophrenia broadly, because schizophrenia is a lifelong condition that requires ongoing management, not a single intervention.

The good news: when schizophrenia symptoms are consistently addressed over time, catatonic episodes are far less likely to return. Treatment typically involves two main approaches (medication and therapy) and often a combination of both.

1.) Medication

A psychiatrist may recommend one or more of the following medications based on your specific situation:

• Benzodiazepines – The most commonly used medication for catatonic schizophrenia. Taken over several days to weeks, benzodiazepines can work quickly to reduce catatonia symptoms effectively. ¹³

• Barbiturates – These work by suppressing the central nervous system (CNS) and have shown effectiveness in relieving catatonic symptoms. However, they carry a high risk of dependence, which is why they’re prescribed less frequently than benzodiazepines. ¹⁴

• Antidepressants – Many people with catatonic schizophrenia also live with a co-occurring condition such as depression. In these cases, antidepressants may be prescribed alongside other medications. ¹⁵

• Antipsychotics – To manage the broader symptoms of schizophrenia long-term, a mental health professional may recommend antipsychotic medication. ¹⁶ Finding the right one can take time, as these drugs affect people differently, so some patience is usually part of the process.

All medications should only be taken exactly as prescribed by your doctor.

2.) Therapeutic Treatments

Medication alone isn’t always enough. Therapy plays an equally important role in recovery and long-term stability. Options include:

• Psychotherapies – The most widely used therapeutic approach for mental health conditions, psychotherapy helps you identify harmful thought and behavior patterns and build healthier coping mechanisms. It’s worth noting that psychotherapy tends to be less effective during severe catatonic episodes, making it more appropriate during periods of stability. ¹⁷

• Electroconvulsive Therapy (ECT) – When medication and other treatments haven’t produced results, ECT may be considered. The procedure involves passing a carefully controlled electrical current through the brain to produce a brief, monitored seizure. Side effects do occur, but are typically temporary. ¹⁸

• Social and Vocational Skills Training – Recovering from a catatonic episode can make everyday life feel unfamiliar. This type of training helps rebuild practical skills (personal hygiene, meal preparation, communication) and can connect you with support for finding work, housing, and peer groups. ¹⁹

In more severe cases, hospitalization may be necessary to ensure the person receives the level of care and monitoring their condition requires.

Other Treatment Options: All-Natural Alternatives

Over the past few decades, natural and complementary approaches have grown in popularity among people managing mental health conditions. These alternatives aren’t a replacement for what your doctor prescribes, but many people use them alongside traditional medications and therapies for additional support.

Here are some options that research suggests may be beneficial for schizophrenia:

• Vitamin Supplementation – People with schizophrenia often have lower blood levels of folic acid (vitamin B9). ²⁰ A 2014 research review found that B vitamins (including B6 and B12) may help reduce symptoms. ²¹ Vitamins C, D, and E have also shown benefits, particularly in adolescents with schizophrenia. ²²

• Omega-3 Fatty Acids – Fish oil supplements are a rich source of omega-3 fatty acids, which may help reduce inflammation. This matters because some research links chronic inflammation to mental illness. ²³ In one study, young people at high risk of schizophrenia were less likely to develop the condition when they took fish oil supplements regularly. ²⁴

• Glycine – An amino acid that works alongside glutamine to support brain function. Some studies suggest that high doses of glycine may enhance the effectiveness of antipsychotic medications used in schizophrenia treatment. One important exception: glycine has been shown to reduce the effectiveness of clozapine specifically, so this should always be discussed with a doctor before use. ²⁵

Diet also plays a meaningful role. Some research suggests that a gluten-free diet may help reduce schizophrenia symptoms, and eating well overall supports the brain-gut connection (the communication pathway between your digestive system and brain), which can improve your ability to manage symptoms day to day. ²⁶

Catatonic Schizophrenia Complications

When catatonic schizophrenia goes untreated, the effects extend well beyond mental health. Over time, the condition can create serious challenges across multiple areas of a person’s life, including their physical health, relationships, finances, and personal safety.

Potential complications include: ²⁷

• Depression and suicidal ideation
• Family conflicts
• Hygiene difficulties
• Inability to attend school or maintain a job
• Malnutrition
• Prison (getting involved in a crime)
• Smoking-related health conditions
• Substance abuse

---

If you or someone you love is thinking about suicide, please reach out for help now.

Contact the 988 Suicide & Crisis Lifeline by calling or texting 988. It’s free, confidential, and available 24/7. If there is immediate danger, call 911 or go to your nearest emergency room.

---

Final Word

Catatonic schizophrenia is serious, but it’s treatable. With the right care plan, episodes can be managed effectively, and the broader symptoms of schizophrenia become more manageable over time.

Recovery isn’t linear, and it isn’t easy. But with consistent treatment and a strong support system, living a full and meaningful life is possible.

If you think you or someone you love may be experiencing symptoms, don’t wait. Reaching out to a mental health professional is the most important first step you can take.

Frequently Asked Questions (FAQs)

References

¹ Jain A, Mitra P. Catatonic Schizophrenia. 2023 Jul 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 33085369.

² Rasmussen SA, Mazurek MF, Rosebush PI. Catatonia: Our current understanding of its diagnosis, treatment and pathophysiology. World J Psychiatry. 2016 Dec 22;6(4):391-398. doi: 10.5498/wjp.v6.i4.391. PMID: 28078203; PMCID: PMC5183991.

³ Hany M, Rehman B, Rizvi A, Chapman J. Schizophrenia. 2024 Feb 23. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 30969686.

⁴ Popovic D, Schmitt A, Kaurani L, Senner F, Papiol S, Malchow B, Fischer A, Schulze TG, Koutsouleris N, Falkai P. Childhood Trauma in Schizophrenia: Current Findings and Research Perspectives. Front Neurosci. 2019 Mar 21;13:274. doi: 10.3389/fnins.2019.00274. PMID: 30983960; PMCID: PMC6448042.

⁵ Brown AS, Susser ES. Prenatal nutritional deficiency and risk of adult schizophrenia. Schizophr Bull. 2008 Nov;34(6):1054-63. doi: 10.1093/schbul/sbn096. Epub 2008 Aug 4. PMID: 18682377; PMCID: PMC2632499.

⁶ Gejman PV, Sanders AR, Duan J. The role of genetics in the etiology of schizophrenia. Psychiatr Clin North Am. 2010 Mar;33(1):35-66. doi: 10.1016/j.psc.2009.12.003. PMID: 20159339; PMCID: PMC2826121.

⁷ Brown AS, Schaefer CA, Wyatt RJ, Begg MD, Goetz R, Bresnahan MA, Harkavy-Friedman J, Gorman JM, Malaspina D, Susser ES. Paternal age and risk of schizophrenia in adult offspring. Am J Psychiatry. 2002 Sep;159(9):1528-33. doi: 10.1176/appi.ajp.159.9.1528. PMID: 12202273; PMCID: PMC2989614.

⁸ Cattaneo A, Riva MA. Stress-induced mechanisms in mental illness: A role for glucocorticoid signalling. J Steroid Biochem Mol Biol. 2016 Jun;160:169-74. doi: 10.1016/j.jsbmb.2015.07.021. Epub 2015 Aug 1. PMID: 26241031.

⁹ Corcoran C, Mujica-Parodi L, Yale S, Leitman D, Malaspina D. Could stress cause psychosis in individuals vulnerable to schizophrenia? CNS Spectr. 2002 Jan;7(1):33-8, 41-2. doi: 10.1017/s1092852900022240. PMID: 15254447; PMCID: PMC2774708.

¹⁰ Kneeland RE, Fatemi SH. Viral infection, inflammation and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Apr 5;42:35-48. doi: 10.1016/j.pnpbp.2012.02.001. Epub 2012 Feb 10. PMID: 22349576; PMCID: PMC3408569.

¹¹ Winklbaur B, Ebner N, Sachs G, Thau K, Fischer G. Substance abuse in patients with schizophrenia. Dialogues Clin Neurosci. 2006;8(1):37-43. doi: 10.31887/DCNS.2006.8.1/bwinklbaur. PMID: 16640112; PMCID: PMC3181760.

¹² Bhati MT, Datto CJ, O’Reardon JP. Clinical manifestations, diagnosis, and empirical treatments for catatonia. Psychiatry (Edgmont). 2007 Mar;4(3):46-52. PMID: 20805910; PMCID: PMC2922358.

¹³ Zaman H, Gibson RC, Walcott G. Benzodiazepines for catatonia in people with schizophrenia or other serious mental illnesses. Cochrane Database Syst Rev. 2019 Aug 5;8(8):CD006570. doi: 10.1002/14651858.CD006570.pub3. PMID: 31425609; PMCID: PMC6699646.

¹⁴ Fink M. Catatonia: a syndrome appears, disappears, and is rediscovered. Can J Psychiatry. 2009 Jul;54(7):437-45. doi: 10.1177/070674370905400704. PMID: 19660165.

¹⁵ Chen MJ, Huang SS, Juang KD, Chan CH. Successful treatment of treatment-resistant schizophrenia in a 10-year-catatonic patient by augmentation of selective serotonin reuptake inhibitors: a case report. Medicine (Baltimore). 2015 May;94(17):e769. doi: 10.1097/MD.0000000000000769. PMID: 25929916; PMCID: PMC4603060.

¹⁶ Bruijnzeel D, Suryadevara U, Tandon R. Antipsychotic treatment of schizophrenia: an update. Asian J Psychiatr. 2014 Oct;11:3-7. doi: 10.1016/j.ajp.2014.08.002. Epub 2014 Aug 13. PMID: 25216917.

¹⁷ Eells TD. Psychotherapy of Schizophrenia. J Psychother Pract Res. 2000 Oct;9(4):250-254. PMID: 11069278; PMCID: PMC3330613.

¹⁸ Luchini F, Medda P, Mariani MG, Mauri M, Toni C, Perugi G. Electroconvulsive therapy in catatonic patients: Efficacy and predictors of response. World J Psychiatry. 2015 Jun 22;5(2):182-92. doi: 10.5498/wjp.v5.i2.182. PMID: 26110120; PMCID: PMC4473490.

¹⁹ Kopelowicz A, Liberman RP, Zarate R. Recent advances in social skills training for schizophrenia. Schizophr Bull. 2006 Oct;32 Suppl 1(Suppl 1):S12-23. doi: 10.1093/schbul/sbl023. Epub 2006 Aug 2. PMID: 16885207; PMCID: PMC2632540.

²⁰ Saedisomeolia A, Djalali M, Moghadam AM, Ramezankhani O, Najmi L. Folate and vitamin B12 status in schizophrenic patients. J Res Med Sci. 2011 Mar;16 Suppl 1(Suppl1):S437-41. PMID: 22247731; PMCID: PMC3252772.

²¹ Brown HE, Roffman JL. Vitamin supplementation in the treatment of schizophrenia. CNS Drugs. 2014 Jul;28(7):611-22. doi: 10.1007/s40263-014-0172-4. PMID: 24846474; PMCID: PMC4083629.

²² Cornish S, Mehl-Madrona L. The role of vitamins and minerals in psychiatry. Integr Med Insights. 2008;3:33-42. Epub 2008 Sep 24. PMID: 21614157; PMCID: PMC3046018.

²³ Firth J, Veronese N, Cotter J, Shivappa N, Hebert JR, Ee C, Smith L, Stubbs B, Jackson SE, Sarris J. What Is the Role of Dietary Inflammation in Severe Mental Illness? A Review of Observational and Experimental Findings. Front Psychiatry. 2019 May 15;10:350. doi: 10.3389/fpsyt.2019.00350. PMID: 31156486; PMCID: PMC6529779.

²⁴ Amminger GP, Schäfer MR, Schlögelhofer M, Klier CM, McGorry PD. Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study. Nat Commun. 2015 Aug 11;6:7934. doi: 10.1038/ncomms8934. PMID: 26263244; PMCID: PMC4918317.

²⁵ Javitt DC, Silipo G, Cienfuegos A, Shelley AM, Bark N, Park M, Lindenmayer JP, Suckow R, Zukin SR. Adjunctive high-dose glycine in the treatment of schizophrenia. Int J Neuropsychopharmacol. 2001 Dec;4(4):385-91. doi: 10.1017/S1461145701002590. PMID: 11806864.

²⁶ Kalaydjian AE, Eaton W, Cascella N, Fasano A. The gluten connection: the association between schizophrenia and celiac disease. Acta Psychiatr Scand. 2006 Feb;113(2):82-90. doi: 10.1111/j.1600-0447.2005.00687.x. PMID: 16423158.

²⁷ Gross AF, Smith FA, Stern TA. Dread complications of catatonia: a case discussion and review of the literature. Prim Care Companion J Clin Psychiatry. 2008;10(2):153-5. doi: 10.4088/pcc.v10n0210. PMID: 18458717; PMCID: PMC2292429.